Norepinephrine and impulsivity: effects of acute yohimbine

[1]  J. Endicott,et al.  Schedule for Affective Disorders and Schizophrenia , 2014 .

[2]  G. Aston-Jones,et al.  Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons , 2013, Neuropharmacology.

[3]  N. Paterson,et al.  Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat. , 2012, The international journal of neuropsychopharmacology.

[4]  T. Robbins,et al.  Norepinephrine and Dopamine Modulate Impulsivity on the Five-Choice Serial Reaction Time Task Through Opponent Actions in the Shell and Core Sub-Regions of the Nucleus Accumbens , 2012, Neuropsychopharmacology.

[5]  JaneR . Taylor,et al.  Chronic Corticosterone Exposure during Adolescence Reduces Impulsive Action but Increases Impulsive Choice and Sensitivity to Yohimbine in Male Sprague-Dawley Rats , 2012, Neuropsychopharmacology.

[6]  M. Atzori,et al.  α2- and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity , 2012, Psychopharmacology.

[7]  C. Winstanley.  The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders , 2011, British journal of pharmacology.

[8]  Paulo Henrique Paiva de Moraes,et al.  The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. , 2011, Journal of affective disorders.

[9]  A. Arnsten,et al.  Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders , 2011, Pharmacology Biochemistry and Behavior.

[10]  T. Robbins,et al.  Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists , 2011, Psychopharmacology.

[11]  R. Sinha,et al.  A pilot examination of stress-related changes in impulsivity and risk taking as related to smoking status and cessation outcome in adolescents. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[12]  Kimberly L. Kjome,et al.  Criminal conviction, impulsivity, and course of illness in bipolar disorder , 2011, Bipolar disorders.

[13]  P. Fitzgerald.  A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex? , 2011, Psychopharmacology.

[14]  Andy D Weyer,et al.  Involvement of Noradrenergic Neurotransmission in the Stress- but not Cocaine-Induced Reinstatement of Extinguished Cocaine-Induced Conditioned Place Preference in Mice: Role for β-2 Adrenergic Receptors , 2010, Neuropsychopharmacology.

[15]  Danielle L. Graham,et al.  Yohimbine Increases Impulsivity Through Activation of cAMP Response Element Binding in the Orbitofrontal Cortex , 2010, Biological Psychiatry.

[16]  Edward T Bullmore,et al.  Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review , 2010, Neuropsychopharmacology.

[17]  J. Patton,et al.  Fifty years of the Barratt Impulsiveness Scale: An update and review , 2009 .

[18]  C. Tung,et al.  Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task , 2009, Journal of Biomedical Sciences.

[19]  F Gerard Moeller,et al.  Trait impulsivity and response inhibition in antisocial personality disorder. , 2009, Journal of psychiatric research.

[20]  P. Fletcher,et al.  The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats , 2009, Psychopharmacology.

[21]  S. Faraone,et al.  Neurocognitive impairment in unaffected siblings of youth with bipolar disorder , 2008, Psychological Medicine.

[22]  B. Reynolds,et al.  Dimensions of impulsive behavior in adolescents: laboratory behavioral assessments. , 2008, Experimental and clinical psychopharmacology.

[23]  Jonathan D. Cohen,et al.  Adaptive gain and the role of the locus coeruleus–norepinephrine system in optimal performance , 2005, The Journal of comparative neurology.

[24]  D. Dougherty,et al.  Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. , 2005, The American journal of psychiatry.

[25]  D. Dougherty,et al.  Acute Yohimbine Increases Laboratory-Measured Impulsivity in Normal Subjects , 2005, Biological Psychiatry.

[26]  Antoni Rodríguez-Fornells,et al.  Noradrenergic Stimulation Enhances Human Action Monitoring , 2005, The Journal of Neuroscience.

[27]  A. Arnsten,et al.  Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder , 2005, Behavioral and Brain Functions.

[28]  M. Geyer,et al.  Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not α2-adrenoceptors , 2005, Psychopharmacology.

[29]  A. Arnsten,et al.  Locomotor hyperactivity induced by blockade of prefrontal cortical α2-adrenoceptors in monkeys , 2005, Biological Psychiatry.

[30]  Suzanne R. Best,et al.  Association between childhood trauma and catecholamine response to psychological stress in police academy recruits , 2005, Biological Psychiatry.

[31]  R. Rothman,et al.  Evidence for alterations in α2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration , 2004, Neuroscience.

[32]  D. Dougherty,et al.  Laboratory measured behavioral impulsivity relates to suicide attempt history. , 2004, Suicide & life-threatening behavior.

[33]  A. Arnsten,et al.  Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions , 2004, Biological Psychiatry.

[34]  G.Y. Li,et al.  Involvement of the Noradrenergic System in Performance on a Continuous Task Requiring Effortful Attention , 2004, Neuropsychobiology.

[35]  D. Hommer,et al.  Impulsivity in abstinent alcohol-dependent patients: relation to control subjects and type 1-/type 2-like traits. , 2004, Alcohol.

[36]  J. Bjork,et al.  Behavioral impulsivity paradigms: a comparison in hospitalized adolescents with disruptive behavior disorders. , 2003, Journal of child psychology and psychiatry, and allied disciplines.

[37]  P. Whitton,et al.  Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of α2 and 5-HT1A receptors , 2003, Neuroscience Letters.

[38]  S. Lane,et al.  Relationships Among Laboratory and Psychometric Measures of Impulsivity: Implications in Substance Abuse and Dependence , 2003 .

[39]  C. Berridge,et al.  The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.

[40]  J. Bjork,et al.  Familial Transmission of Continuous Performance Test Behavior: Attentional and Impulsive Response Characteristics , 2003, The Journal of general psychology.

[41]  J. Bjork,et al.  Two models of impulsivity: relationship to personality traits and psychopathology , 2002, Biological Psychiatry.

[42]  E. Barratt,et al.  Psychiatric aspects of impulsivity. , 2001, The American journal of psychiatry.

[43]  S. A. Abdali,et al.  Rate-independent inhibition by norepinephrine of 5-HT release from the somadendritic region of serotonergic neurons , 2001, Brain Research Bulletin.

[44]  A. Arnsten,et al.  Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats , 2000, Pharmacology Biochemistry and Behavior.

[45]  C. Nemeroff,et al.  Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. , 2000, The Journal of clinical endocrinology and metabolism.

[46]  Colin Studholme,et al.  The Alpha-2A-Adrenoceptor Agonist, Guanfacine, Increases Regional Cerebral Blood Flow in Dorsolateral Prefrontal Cortex of Monkeys Performing a Spatial Working Memory Task , 2000, Neuropsychopharmacology.

[47]  M. Carli,et al.  The 5-HT1A receptor agonist 8-OH-DPAT reduces rats’ accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT1A receptors , 2000, Psychopharmacology.

[48]  M. Millan,et al.  Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2‐adrenergic receptors (AR)s, serotonin (5‐HT)1A, 5‐HT1B, 5‐HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states , 2000, Synapse.

[49]  JaneR . Taylor,et al.  A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortex , 1999, Biological Psychiatry.

[50]  J. Evenden.  Varieties of impulsivity , 1999, Psychopharmacology.

[51]  JaneR . Taylor,et al.  α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function , 1999, Biological Psychiatry.

[52]  B. Sanders,et al.  Interaction of GABA and Excitatory Amino Acids in the Basolateral Amygdala: Role in Cardiovascular Regulation , 1997, The Journal of Neuroscience.

[53]  Y. Mizuki,et al.  Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[54]  A. Iwanami,et al.  Plasma vanillylmandelic acid level as an index of psychological stress response in normal subjects , 1996, Psychiatry Research.

[55]  S. Woods,et al.  Effects of tryptophan depletion on responses to yohimbine in healthy human subjects , 1995, Biological Psychiatry.

[56]  B. Szabo,et al.  Mechanism of Sympathoinhibition by Imidazolines , 1995, Annals of the New York Academy of Sciences.

[57]  A. Jaffer,et al.  β2 Mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder , 1995, Neurochemical Research.

[58]  T. Zahn,et al.  Anxiogenic properties of yohimbine , 1992, European Archives of Psychiatry and Clinical Neuroscience.

[59]  P. Whybrow,et al.  Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. , 1991, Archives of general psychiatry.

[60]  D. Goldstein,et al.  Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats , 1991, Brain Research.

[61]  F. Gonon,et al.  An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. , 1991, The Journal of pharmacology and experimental therapeutics.

[62]  T. Uhde,et al.  Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls , 1990, Psychoneuroendocrinology.

[63]  Trevor W. Robbins,et al.  Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: Implications for theories of selective attention and arousal , 1989, Behavioural Brain Research.

[64]  G. Gerhardt,et al.  Reproducibility of the measurement of plasma noradrenergic and dopaminergic metabolites in normal subjects , 1988, Psychiatry Research.

[65]  S. Koslow,et al.  Lithium carbonate treatment of mania , 1988 .

[66]  E. Robins,et al.  Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. , 1987, Archives of general psychiatry.

[67]  D. Charney,et al.  Three cases of manic symptoms following yohimbine administration. , 1984, The American journal of psychiatry.

[68]  M. Scheinin,et al.  Measurement of 3-methoxy-4-hydroxyphenylglycol in human plasma with high-performance liquid chromatography using electrochemical detection. , 1983, Analytical biochemistry.

[69]  D. Charney,et al.  Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbine , 1982 .

[70]  H. Landis,et al.  Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin. , 1980, Life sciences.

[71]  N. M. Greene,et al.  3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo. , 1979, Science.

[72]  Dennis L. Murphy,et al.  Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment , 1975, Psychopharmacologia.

[73]  J. Maas,et al.  In vivo studies of the metabolism of norepinephrine in the central nervous system. , 1968, The Journal of pharmacology and experimental therapeutics.

[74]  C. Winstanley,et al.  Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex , 2011, Psychopharmacology.

[75]  D. Dougherty,et al.  Impulsivity and phase of illness in bipolar disorder. , 2003, Journal of affective disorders.

[76]  M. Carli,et al.  The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. , 2000, Psychopharmacology.

[77]  A. Arnsten,et al.  Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine α-1 receptor mechanisms , 2000 .

[78]  V. Russell,et al.  Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. , 1995, Neurochemical research.

[79]  T. Zahn,et al.  Anxiogenic properties of yohimbine. II. Influence of experimental set and setting. , 1992, European archives of psychiatry and clinical neuroscience.

[80]  E. Peskind,et al.  Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans. , 1989, Neuroendocrinology.

[81]  C. Izard,et al.  Motivation, emotion, and personality , 1985 .

[82]  D. Charney,et al.  Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. , 1982, Life sciences.

[83]  G. Aghajanian.  Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. , 1978, Essays in neurochemistry and neuropharmacology.

[84]  Aghajanian Gk.  Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. , 1978 .

[85]  D. M. Green,et al.  Signal detection theory and psychophysics , 1966 .